-
The Effects of Memantine on Levodopa Induced Dyskinesias (LIDs) in MPTP-treated Pre-clinical Models
… NMDA receptors, providing a rationale for its use to treat dyskinesias. However, memantine is an especially …
-
In Vitro Electrophysiological Studies in Experimental Models of Dyskinesias
… early stages, chronic treatment leads to the development of dyskinesias or movement abnormalities. These can be very …
-
Mechanisms of Graft-Induced Dyskinesias in an Animal Model of Parkinson's Disease
… patients developed postoperative, graft-induced dyskinesias (GID). Our project has four aims: To develop a …
-
5-Hydroxytryptophan and Eltoprazine for the Treatment of Levodopa-Induced Dyskinesia
… Objective/Rationale: The appearance of dyskinesia presents new challenges as a symptom of long-term … of the serotonin neurons have been shown to suppress dyskinesia. Project Description: In this …
-
Mechanisms of Graft-Induced Dyskinesias in an Animal Model of Parkinson's Disease (Supplemental Funding)
… research from a prior grant: Mechanisms of Graft-Induced Dyskinesias in an Animal Model of Parkinson's Disease Our …
-
A Trial of Low Frequency Repetitive Transcranial Magnetic Stimulation for Treatment of Dyskinesia
… Levodopa-induced dyskinesia (LID) is a major source of disability of many … a 10-day course of low frequency rTMS of the motor cortex. Dyskinesia will be assessed by the response to a dose of …